Can antidepressants prevent interferon-alpha-induced depression? A review of the literature

Can antidepressants prevent interferon-alpha-induced depression? A review of the literature

Author Galvao-de Almeida, Amanda Autor UNIFESP Google Scholar
Guindalini, Camila Autor UNIFESP Google Scholar
Batista-Neves, Susana Google Scholar
Oliveira, Irismar R. de Google Scholar
Miranda-Scippa, Angela Google Scholar
Quarantini, Lucas C. Google Scholar
Institution Universidade Federal da Bahia (UFBA)
Universidade Federal de São Paulo (UNIFESP)
Lab Interdisciplinar Neurociencias Clin LiNC
Abstract Objective: To review the literature about the efficacy of antidepressant prophylaxis during interferon-alpha (IFN-alpha) therapy.Method: We have performed a database search in PUBMED and ISI Web of Knowledge (1980-August 2009) for the available literature. the keywords prevention or prophylaxis, and depression, and interferon, and antidepressant or antidepressive agents were used.Results: the six eligible studies comprise three randomized controlled trials, two in hepatitis C virus (HCV) patients and one in individuals with melanoma, and three open-label studies with HCV patients. the results of the randomized controlled trials suggest that antidepressant prophylaxis may blunt the magnitude of depressive symptoms in HCV patients and raise the rates of treatment completion. in melanoma patients, this preventive strategy may reduce the incidence of depression during IFN-alpha treatment. in addition, the open-label studies with HCV patients suggest that this strategy may reduce the onset of major depression in specific samples (current psychiatric diagnosis, major depression in remission, past history of IFN-alpha-induced depression) on IFN-alpha (re-)treatment.Conclusions: in the face of so few trials about the usefulness of prophylaxis with antidepressants before IFN-alpha treatment, there is not enough information to sufficiently and widely support this strategy to prevent depression. However, this approach may, nonetheless, bring some beneficial outcomes, if applied to specific patient groups. (C) 2010 Elsevier Inc. All rights reserved.
Keywords Major depression
Interferon-alpha
Prevention
Antidepressant
Review
Language English
Sponsor Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Grant number CNPq: 142262/2008-0
Date 2010-07-01
Published in General Hospital Psychiatry. New York: Elsevier B.V., v. 32, n. 4, p. 401-405, 2010.
ISSN 0163-8343 (Sherpa/Romeo, impact factor)
Publisher Elsevier B.V.
Extent 401-405
Origin http://dx.doi.org/10.1016/j.genhosppsych.2010.03.001
Access rights Closed access
Type Review
Web of Science ID WOS:000280389800007
URI http://repositorio.unifesp.br/handle/11600/32674

Show full item record




File

File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Search


Browse

Statistics

My Account